Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clarithromycin for Prevention of Chronic Lung Disease in Premature Infants
NCT01326611Phase 4Completed
- Sponsor
- Zekai Tahir Burak Women's Health Research and Education Hospital
- Start
- May 2008
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clarithromycin in chronic lung disease, sponsored by Zekai Tahir Burak Women's Health Research and Education Hospital. Started May 2008; status: completed.
02
Drugs
clarithromycin
03
Conditions
chronic lung disease
Beyond the preview
Go deeper on NCT01326611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01326611.